Role of fluorescence guided surgery for detection of peritoneal metastases in epithelial ovarian cancer patients

Fluorescence guided surgery using Near-infrared (NIR) imaging for detection of peritoneal metastases in patients undergoing cytoreductive surgery in epithelial ovarian cancer-A feasibility study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/073145

Enrollment

Registered

2024-08-30

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: Fluorescence guided surgery using Near-infrared (NIR) imaging using indocyanine green in patients undergoing cytoreductive surgery in epithelial ovarian cancer : After confirmation of

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients diagnosed with epithelial ovarian cancer with peritoneal metastases undergoing Primary or interval cytoreductive Surgery 2. Age= 18yearsold 3. Able to give informed consent. 4. ECOG Performance Score 0-2

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. History of allergy or hypersensitivity against ICG or lodine compounds. 2. Pregnancy and lactation. 3. Prior and current history of Bevacizumab administration. 4. Mucinous Histology. 5. ECOG Performance score 3-4 6. Surgically not meeting resectablity criteria

Design outcomes

Primary

Measure	Time frame
Concordance between fluorescent signal-detected peritoneal metastases and histopathology assessmentTimepoint: 4 WEEKS OF SURGERY	—

Secondary

Measure	Time frame
Concordance between fluorescent signal-detected lymph nodes and residual and histopathology assessmentTimepoint: 24 months	—

Countries

India

Contacts

Public ContactRICHA GARG

AIIMS NEW DELHI

drseemasinghal@gmail.com9818291001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026